蛋白质组学分析揭示塌陷型FSGS独特的肾小球细胞外基质
本研究采用质谱蛋白质组学比较塌陷型FSGS(cFSGS)、非特指型FSGS(FSGS-NOS)及正常对照的肾小球细胞外基质(ECM)组成,发现cFSGS与FSGS-NOS之间有58种ECM蛋白丰度差异,其中41种在cFSGS中更高。组织学验证显示cFSGS肾小球中组织蛋白酶B、C和膜联蛋白A3染色显著增强,且这些蛋白与活化的壁上皮细胞(PEC)标志物共定位,提示PEC浸润可能破坏ECM重塑。
要点
- cFSGS与FSGS-NOS的肾小球ECM蛋白组成存在显著差异,cFSGS中41种蛋白丰度更高。
- cFSGS肾小球中组织蛋白酶B、C和膜联蛋白A3表达显著高于其他FSGS变异型、微小病变和膜性肾病。
- 尿液中组织蛋白酶B和C排泄在cFSGS中显著高于FSGS-NOS,可能作为无创标志物。
核心结论
- cFSGS的肾小球硬化机制与其他FSGS变异型不同,活化的壁上皮细胞浸润可能破坏ECM重塑。
- 组织蛋白酶B、C和膜联蛋白A3可能成为cFSGS的治疗靶点。
研究设计与样本
- 研究类型:病例对照蛋白质组学研究。
- 样本:FSGS-NOS、cFSGS患者肾活检标本及正常对照。
- 方法:质谱定量ECM蛋白,免疫组化和共聚焦显微镜验证定位,并评估基因表达和尿液ECM蛋白/肽段排泄。
主要发现
- 58种ECM蛋白在cFSGS和FSGS-NOS间丰度差异,其中41种在cFSGS中更丰富,17种在FSGS-NOS中更丰富。
- 免疫组化显示cFSGS肾小球丛中组织蛋白酶B、C和膜联蛋白A3染色显著强于其他FSGS变异型、微小病变和膜性肾病。
- 膜联蛋白A3与组织蛋白酶B、C、claudin-1、磷酸化ERK1/2和CD44共定位,但不与synaptopodin共定位,位于浸润cFSGS肾小球的壁上皮细胞中。
- FSGS肾小球中组织蛋白酶B和C的转录本较正常对照增加,且cFSGS尿液中这两种组织蛋白酶排泄显著高于FSGS-NOS。
- cFSGS尿液中ECM来源肽段排泄增强,但计算机分析未发现组织蛋白酶B或C来源肽段排泄增强。
临床怎么用
- 对于cFSGS患者,可考虑检测尿液组织蛋白酶B和C排泄作为辅助诊断或活动性监测指标。
- 靶向活化的壁上皮细胞及其组织蛋白酶可能为cFSGS提供新的治疗策略。
局限性
- 研究未报告样本量、P值或置信区间,统计效能不明确。
- 尿液肽段计算机分析未发现组织蛋白酶来源肽段排泄增强,机制尚需进一步验证。
- 仅进行蛋白质组学和小规模验证,未开展功能实验或治疗干预研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The mechanisms leading to extracellular matrix (ECM) replacement of areas of glomerular capillaries in histologic variants of FSGS are unknown. This study used proteomics to test the hypothesis that glomerular ECM composition in collapsing FSGS (cFSGS) differs from that of other variants. METHODS: ECM proteins in glomeruli from biopsy specimens of patients with FSGS not otherwise specified (FSGS-NOS) or cFSGS and from normal controls were distinguished and quantified using mass spectrometry, verified and localized using immunohistochemistry (IHC) and confocal microscopy, and assessed for gene expression. The analysis also quantified urinary excretion of ECM proteins and peptides. RESULTS: Of 58 ECM proteins that differed in abundance between cFSGS and FSGS-NOS, 41 were more abundant in cFSGS and 17 in FSGS-NOS. IHC showed that glomerular tuft staining for cathepsin B, cathepsin C, and annexin A3 in cFSGS was significantly greater than in other FSGS variants, in minimal change disease, or in membranous nephropathy. Annexin A3 colocalized with cathepsin B and C, claudin-1, phosphorylated ERK1/2, and CD44, but not with synaptopodin, in parietal epithelial cells (PECs) infiltrating cFSGS glomeruli. Transcripts for cathepsins B and C were increased in FSGS glomeruli compared with normal controls, and urinary excretion of both cathepsins was significantly greater in cFSGS compared with FSGS-NOS. Urinary excretion of ECM-derived peptides was enhanced in cFSGS, although in silico analysis did not identify enhanced excretion of peptides derived from cathepsin B or C. CONCLUSIONS: ECM differences suggest that glomerular sclerosis in cFSGS differs from that in other FSGS variants. Infiltration of activated PECs may disrupt ECM remodeling in cFSGS. These cells and their cathepsins may be therapeutic targets.
引用
- Merchant ML, Barati MT, Caster DJ, et al. Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis. J Am Soc Nephrol. 2020. PMID: 32561683. doi:10.1681/ASN.2019070696
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。